Dear State Technical and Rebate Contacts,
This is a follow-up to the May 10, 2023 email reminder to states regarding preparation for the upcoming 2022 Branded Prescription Drug (BPD) Fee Year.
Reporting of State Drug Utilization Data for Branded Drug Fee Calculation
Collections:
Dear Manufacturer Technical and Invoice Contacts,
This is a follow-up to the May 10, 2023 email reminder to manufacturers regarding preparation for the upcoming 2022 Branded Prescription Drug (BPD) Fee Year.
Reporting of State Drug Utilization Data for Branded Drug Fee Calculation
Collections:
Dear Manufacturer Technical and Invoice Contacts,
Collections:
This amendment proposes Clinical Quality Incentive (CQI) payments for privately-owned psychiatric hospitals and substance abuse treatment hospitals.
This amendment authorizes RY 2024 supplemental payments for high-complexity care in pediatric CDR hospitals.
One time supplemental payment for private providers of Intermediate Care Facilities for Individuals with Intellectual Disabilities (ICF/IID) services.
This plan implements numerous updates to rates and methodology under clinic services.
This plan amendment updates the methods and standards used to determine the rates for acute outpatient hospitals.
This amendment would expand providers who are eligible to furnish case management services for two Target Case Management Groups (TCM). (Children at risk ages 0-5 and pregnant women), by revising the provider qualifications.
